As winter approaches, US equity investors are weighing brightening prospects for a Covid-19 vaccine against a resurgence of the pandemic across the United States. Several market strategists have predicted significant gains in US stocks in 2021, as long as Congress passes further fiscal stimulus and a vaccine becomes widely available in the first half. But the path for stocks could be bumpy while investors await those developments, they said. Over the past few weeks, investors had largely looked past immediate risks from the pandemic. The benchmark S&P 500 index recently soared to record highs on evidence of high efficacy rates in two experimental vaccines – from Moderna Inc and jointly from
Hence then, the article about wall street investors weighing prospects for covid 19 vaccine was published today ( ) and is available onٌRayaٌ news ( Qatar ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Wall Street investors weighing prospects for Covid-19 vaccine )